Candriam S.C.A. Incyte Corp Transaction History
Candriam S.C.A.
- $15.6 Billion
- Q1 2025
A detailed history of Candriam S.C.A. transactions in Incyte Corp stock. As of the latest transaction made, Candriam S.C.A. holds 868,545 shares of INCY stock, worth $58.4 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
868,545
Previous 1,034,652
16.05%
Holding current value
$58.4 Million
Previous $71.5 Million
26.41%
% of portfolio
0.34%
Previous 0.42%
Shares
31 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.07 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.44 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.34 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$999 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$675 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...